Alira Health

Presentation: Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain

Tuesday, January 23 | 3 PM CET

Proyecto piloto para la inclusión de la voz del paciente en comités regionales de evaluación de medicamentos en España

We are pleased to announce that on January 23rd at 3:00 pm CET, we will present the results of the first phase of the “Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain.”

This project aims to support the integration of patient voices in the regional drug and therapeutic committees in Spain.

The presentation is open to the public and no registration is required.

Events
Published on:
January 17, 2024

The first phase results include an overview of the fundamental elements that allowed the inclusion of patients in the evaluation committees in Catalonia (challenges, drivers, and the perspective of patients and clinicians). These results will serve as a foundation for the second phase of the program, which will include the development of a how-to guide for incorporation of patients into the evaluation committees in other Autonomous Communities.

This project is promoted by Alira Health and co-sponsored by CSL Vifor.

Click here to add the event to your calendar

Click here to connect to the streaming directly

Presenters
  • Raül Serra, Coordinador de la Secretaria d’Atenció Sanitària i Participació del Departament de Salut
  • Cristina Montané, Representante de pacientes en Comité de Evaluación – CFT-SISCAT
  • Paco García Barrios, Representante de pacientes en Comité de Evaluación – CFT-SISCAT
  • Elisenda de la Torre, Representante de pacientes en Comité de Evaluación CAMH
  • M. Antònia Mangues, Farmacéutica de Hospital, Miembro en Comités de Evaluación CAMH y de CFT-SISCAT
  • Isabel de la Paz, Associate Director, Alira Health
  • Marta Valls, Rare Disease & Patient Advocacy Lead, CLS Vifor
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.